CellWell record HH-18222
Meta-analysis: melatonin for the treatment of primary sleep disorders.
Ferracioli-Oda E; Qawasmi A; Bloch MH
PloS one ยท 2013
In plain language
A meta-analysis of 19 trials in 1,683 people with primary sleep disorders found melatonin modestly cut the time to fall asleep and improved total sleep time and sleep quality versus placebo, more so at higher doses.
- Studied in
- Human
Cite this record: https://thecellwell.org/studies/HH-18222
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.